Sponsors

Phase III COPD Case Study: 85% of patients were diverse

Recommended

Sponsors

Asthma Case Study: 181% of Inato’s patient enrollment achieved

Sponsors

Phase III CVD: 115% of Inato's patient enrollment achieved

Sponsors

Oncology Case Study: 66% faster enrollment time

Sponsors

Phase III Atopic Dermatitis: 123% of Inato's patient enrollment achieved